iShares Genomics Immunology and Healthcare ETF Rating → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free IDNA Stock Alerts $23.23 -0.51 (-2.15%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy2.67Holdings in IDNA have an aggregate rating of Moderate Buy based on 355 analyst ratings issued in the past year covering 37 companies (75.5% of the portfolio).IDNA Aggregate Price Target$36.8258.50% UpsideHigh Prediction$53.49Average Prediction$36.82Low Prediction$23.37Holdings in IDNA have an aggregate price target of $36.82 and a range of $23.37 to $53.49 covering 37 companies (75.5% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 37 IDNA Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.72%SRPTSarepta Therapeutics$131.82-0.4%4 of 5 stars2.79$160.60 21.8%145.63%RVMDRevolution Medicines$37.25-0.5%4 of 5 stars3.10$41.60 11.7%10Earnings ReportAnalyst RevisionNews Coverage5.38%MRNAModerna$117.31-4.4%3 of 5 stars2.25$126.89 8.2%16Insider Selling4.47%MRKMerck & Co., Inc.$130.06-0.1%5 of 5 stars2.58$131.33 1.0%124.23%REGNRegeneron Pharmaceuticals$973.80+0.6%4 of 5 stars2.70$981.71 0.8%20Positive News3.58%EXELExelixis$21.37-1.8%5 of 5 stars2.63$26.33 23.2%16Short Interest ↑3.57%INCYIncyte$53.06-0.8%5 of 5 stars2.47$74.93 41.2%17Short Interest ↑3.40%IOVAIovance Biotherapeutics$10.97-18.4%5 of 5 stars3.00$24.64 124.6%10Earnings ReportAnalyst ForecastGap DownHigh Trading Volume3.24%BNTXBioNTech$91.67-0.4%2 of 5 stars2.27$118.82 29.6%11Short Interest ↑Analyst Revision2.99%GILDGilead Sciences$65.96+2.1%5 of 5 stars2.39$83.69 26.9%18Analyst Revision2.93%TWSTTwist Bioscience$42.37-1.9%2 of 5 stars3.00$42.50 0.3%62.72%SWTXSpringWorks Therapeutics$40.89-4.8%2 of 5 stars3.00$68.83 68.3%62.26%ACLXArcellx$49.74-5.7%3 of 5 stars3.00$78.20 57.2%12Earnings ReportHigh Trading Volume2.17%GERNGeron$3.80-2.1%4 of 5 stars2.80$6.10 60.5%51.89%BEAMBeam Therapeutics$21.26-5.7%1 of 5 stars2.38$40.18 89.0%13Earnings ReportShort Interest ↑Analyst Revision1.85%DVAXDynavax Technologies$10.73-2.5%4 of 5 stars2.75$25.33 136.1%4Short Interest ↑Analyst Revision1.51%DNAGinkgo Bioworks$0.76-17.3%2 of 5 stars1.80$2.20 189.1%5Earnings ReportAnalyst DowngradeShort Interest ↑Gap DownHigh Trading Volume1.50%DCPHDeciphera Pharmaceuticals$25.360.0%3 of 5 stars2.30$24.17 -4.7%101.48%LGNDLigand Pharmaceuticals$87.28+1.3%5 of 5 stars3.00$116.33 33.3%3Earnings Report1.42%BPMCBlueprint Medicines$106.70-1.5%1 of 5 stars2.50$100.31 -6.0%16Short Interest ↑1.33%IBRXImmunityBio$8.12+0.7%0 of 5 stars2.00$6.00 -26.1%1Gap Down1.28%BCRXBioCryst Pharmaceuticals$5.32-0.4%4 of 5 stars3.00$14.00 163.2%7Earnings Report1.18%FDMT4D Molecular Therapeutics$25.70+0.2%3 of 5 stars3.00$44.22 72.1%10Gap Down1.15%MGNXMacroGenics$3.31-77.4%4 of 5 stars2.60$14.78 346.5%10Earnings ReportAnalyst DowngradeGap DownHigh Trading Volume1.07%VIRVir Biotechnology$9.44-1.3%2 of 5 stars2.57$33.57 255.6%70.99%ABCLAbCellera Biologics$3.83-3.0%2 of 5 stars3.00$16.17 322.1%7Earnings ReportAnalyst Revision0.93%CRSPCRISPR Therapeutics$51.17-4.4%3 of 5 stars2.35$73.93 44.5%17Earnings ReportAnalyst ForecastAnalyst Revision0.92%RCUSArcus Biosciences$16.71+3.5%2 of 5 stars2.88$41.25 146.9%8Earnings ReportAnalyst Revision0.82%ARCTArcturus Therapeutics$27.26+1.8%2 of 5 stars3.00$64.86 137.9%7Analyst ForecastShort Interest ↑0.77%NRIXNurix Therapeutics$13.51-3.2%2 of 5 stars2.83$21.33 57.9%60.62%NVAXNovavax$8.88+98.7%4 of 5 stars2.50$15.33 72.7%4Earnings ReportAnalyst UpgradeGap UpHigh Trading Volume0.56%EDITEditas Medicine$5.32-4.3%3 of 5 stars2.50$13.90 161.3%10Earnings ReportShort Interest ↑Analyst Revision0.53%OABIOmniAb$4.68+2.4%2 of 5 stars3.00$9.00 92.3%4Earnings ReportAnalyst RevisionGap DownHigh Trading Volume0.46%NTLAIntellia Therapeutics$24.46-1.6%4 of 5 stars2.69$66.77 173.0%13Analyst Forecast0.33%CRBUCaribou Biosciences$3.54-3.0%2 of 5 stars2.75$22.50 535.6%4Short Interest ↓Analyst RevisionNews Coverage0.32%XNCRXencor$22.48-4.5%4 of 5 stars2.89$36.25 61.3%9Earnings ReportAnalyst ForecastAnalyst Revision0.25%QUREuniQure$4.92-3.0%2 of 5 stars2.71$26.67 442.0%7Upcoming EarningsAnalyst RevisionNews Coverage This page (NYSEARCA:IDNA) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
